Pipeline
Our flagship candidate, the SPB-20X1, is intended for the treatment of solid cancers. It relies on the proprietary SUPERSPIOs technology to combine precision imaging and targeted magnetic hyperthermia therapy.
Research
R & D
Preclinical Stage
Phase 1
Phase 2
Phase 3
Our lead candidate, SPB-20X1, is designed for the treatment of solid cancers. It leverages proprietary SUPERSPIO technology to combine precision imaging and targeted magnetic hyperthermia therapy.